Aurique Limited approved its un-audited standalone financial results for the quarter and half year ended September 30, 2026, during a board meeting held on October 14, 2026.

The company, formerly known as PAE Limited, disclosed the outcome under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board considered and approved the results along with the limited review report required under Regulation 33 of the same regulations.

Meeting details and disclosures

The board meeting commenced at 4:00 pm and concluded at 4:25 pm. The company submitted the financial results and the statement on the impact of audit qualification of the limited review report to BSE Limited for record and reference.

Sarah Eugene Kantharia, Company Secretary and Compliance Officer, signed the disclosure digitally. The registered office is located in Mumbai, Maharashtra, while the corporate office is based in Ahmedabad, Gujarat.

What the Numbers Show

The source document confirms the procedural approval of financial statements but does not disclose specific revenue, profit, or margin figures for the period ended September 30, 2026. Consequently, no analytical comparison of financial performance metrics can be derived from this filing alone.

Aurique Limited has allotted 78,11,100 fully convertible equity warrants at an issue price of ₹12.00 per warrant on a preferential basis. This third tranche allotment was approved by the Board of Directors during a meeting held on September 28, 2026.

This action follows the earlier allotments of 98,38,200 warrants in the first tranche on September 23, 2026, and 73,50,700 warrants in the second tranche on September 25, 2026. All tranches were issued pursuant to a special resolution passed by members in an Extraordinary General Meeting (EGM) held on September 3, 2026, and subsequent in-principle approvals granted by the BSE on September 22, 2026. The issuance complies with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Allotment Details

The company received 25% of the consideration amount from the proposed allottees as required by regulations. Since these are warrants and not direct share issuances, there is currently no change in the paid-up share capital of the company. The warrants are convertible into equity shares of face value ₹10 each within a maximum period of 18 months from the date of allotment.

What the Numbers Show

The third tranche marks a complete shift to public investor participation, unlike the second tranche which saw significant promoter group involvement. In this latest allotment, both Vishal Ishvarbhai Patel and Patel Vinodbhai Ramabhai fall under the Public category, acquiring 47,34,000 and 30,77,100 warrants respectively. This contrasts with the second tranche where Promoter Group member Rinkal J Patel acquired approximately 57% of the issuance. Across the three disclosed tranches, the company has raised capital through a mix of insider and public participation, with the total warrant count reaching 250,00,000 assuming full conversion.